Abstract
JAK1 Inhibition during CAR-T Cell Treatment Results in Reduction in Various Cytokines That Correlate with Cytokine Release Syndrome (CRS) and Immune Effector Cell (IEC)–Associated Neurotoxicity Syndrome (ICANS) Grades
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have